ARTICLE | Company News
Gilead submits MAA for tenofovir DF
May 4, 2001 7:00 AM UTC
GILD submitted an MAA to the EMEA for its tenofovir disoproxil fumarate reverse transcriptase inhibitor to treat HIV/AIDS. GILD filed an NDA for tenofovir DF earlier this week (see BioCentury Extra, ...